UAE-Based Healthtech BioSapien Secures $8 Million Pre-Series A
Jul 07, 2025
BioSapien, a UAE-based healthtech startup, has extended its Pre-Series A round to over $8 million. The startup, which specialises in cancer-focused drug delivery systems, raised the additional capital from UAE VC firm Globivest alongside a group of international and regional investors.
The funding will be used to advance BioSapien's flagship product - a biodegradable implant designed to deliver chemotherapy directly to tumour sites. The solution aims to reduce systemic toxicity and improve targeted treatment outcomes for cancer patients. The latest capital injection will support regulatory approvals, including FDA pathways, preclinical studies, and commercial pilots in select international markets.
Founded in the US and now operating out of the UAE, BioSapien represents a growing trend of biotech startups relocating to or expanding within the region as healthcare innovation becomes a focal point for MENA investors. With the extended funding round, the company is also looking to expand its research team and build additional partnerships with healthcare providers.
The firm's core mission is to transform how chemotherapy is delivered, making it more efficient, less invasive, and ultimately more effective. According to BioSapien, its technology has already shown promising results in initial lab and animal studies, and the startup is now preparing to move toward first-in-human trials.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
5 hours ago
- Mid East Info
AUS students to benefit from practical training and industry exposure through new partnership with Ghaf Labs
Sharjah, UAE,July 2025 – Following the signing of a Memorandum of Agreement (MOA) between American University of Sharjah (AUS) and Ghaf Labs–FZCO (Ghaf Labs), a Dubai-based blockchain advisory and consultancy firm, AUS students will gain expanded access to internships, research collaborations, field visits and knowledge-sharing opportunities in emerging technical fields. The agreement was signed under the AUS Engineering Al Nukhba Program, which establishes industry collaborations in research, development, training programs, internships, exchange of information and personnel, joint supervision of students' capstone projects and field trip visits. Dr. Fadi Aloul, Dean of the AUS College of Engineering, said: 'This collaboration with Ghaf Labs opens valuable pathways for our students to interact directly with the frontiers of digital innovation,' said Dr. Fadi Aloul, Dean of the AUS College of Engineering. 'We are very excited about this collaboration because it involves Web3, blockchain, AI and advanced technologies—areas we have strategically embedded into all 24 of our programs under CEN 2.0 major curriculum revamp. By engaging with professionals in these emerging sectors, our students will enhance their technical competencies and gain insights into real-world applications that complement their academic training.' Under the agreement, Ghaf Labs will offer internship opportunities that align with students' academic and professional goals. The collaboration also includes joint supervision of selected capstone and research projects whenever feasible, cooperation on research and development initiatives, expert-led sessions and organized visits to industry settings. 'At Ghaf Labs, we believe that shaping the future of technology starts with empowering the next generation. Partnering with AUS allows us to co-create a space where innovation meets education. This collaboration reflects our commitment to cultivating regional talent in blockchain, Web3, and AI. By mentoring students through real-world projects, we're building not just careers—but a thriving safe digital economy,' said Feras Al Sadek, Co-Founder, Board Member and Managing Partner at Ghaf Labs. Ghaf Labs specializes in management consulting, marketing research and consulting, and Distributed Ledger Technology services. They also offer IT consulting for industries involved in Web3, blockchain, the metaverse and other digital asset sectors. This partnership is part of the College of Engineering's broader mission to foster meaningful engagement between academia and industry. Through initiatives like the Al Nukhba Program, the college continues to provide students with access to cutting-edge technologies, real-world challenges and professional networks that prepare them to lead in a rapidly evolving global workforce.
CairoScene
20 hours ago
- CairoScene
UAE-Based Healthtech BioSapien Secures $8 Million Pre-Series A
Backed by Globivest and regional investors, BioSapien's expanded funding round will support regulatory approvals, pilot studies, and broader market expansion of its FDA-cleared drug delivery platform. Jul 07, 2025 BioSapien, a UAE-based healthtech startup, has extended its Pre-Series A round to over $8 million. The startup, which specialises in cancer-focused drug delivery systems, raised the additional capital from UAE VC firm Globivest alongside a group of international and regional investors. The funding will be used to advance BioSapien's flagship product - a biodegradable implant designed to deliver chemotherapy directly to tumour sites. The solution aims to reduce systemic toxicity and improve targeted treatment outcomes for cancer patients. The latest capital injection will support regulatory approvals, including FDA pathways, preclinical studies, and commercial pilots in select international markets. Founded in the US and now operating out of the UAE, BioSapien represents a growing trend of biotech startups relocating to or expanding within the region as healthcare innovation becomes a focal point for MENA investors. With the extended funding round, the company is also looking to expand its research team and build additional partnerships with healthcare providers. The firm's core mission is to transform how chemotherapy is delivered, making it more efficient, less invasive, and ultimately more effective. According to BioSapien, its technology has already shown promising results in initial lab and animal studies, and the startup is now preparing to move toward first-in-human trials.
Mid East Info
21 hours ago
- Mid East Info
Aster Clinics Launches Smyl AI, the UAE's First AI-Powered Dental Screening Tool, Pioneering a New Era of Accessible Dental Care
In a major leap toward accessible and technology-driven oral healthcare, Aster Clinics, a leading integrated healthcare provider under Aster DM Healthcare in the GCC, has officially launched Smyl AI – the UAE's first AI-powered Dental Bot, designed to redefine how dental care is delivered and experienced. Smyl AI offers free, instant dental screenings via WhatsApp, making oral health assessments easier, faster, and more accessible than ever before. The launch of Smyl AI marks the beginning of Aster Clinics' Smarter Smiles initiative in the UAE – dedicated to enhancing awareness, enabling early detection, and promoting proactive dental care across the country. Developed in collaboration with India-based an expert in AI health technology, Smyl AI is the first solution of its kind to be introduced in the UAE dental landscape. The innovative AI-enabled tool empowers users to complete a dental screening in under 2 minutes by answering a few simple questions and uploading three images of their teeth (upper, lower, and front). The AI tool then generates a free dental health report, highlighting potential concerns such as cavities, gum disease, plaque, and stains. Users can then easily schedule a consultation with a dental specialist at their nearest Aster Clinic for further evaluation and care. Speaking about this initiative, Ms. Alisha Moopen, Managing Director and Group CEO, Aster DM Healthcare, said 'Technology holds immense potential to transform healthcare, and Smyl AI is a perfect example of how innovation can bridge the gap between awareness and access. Through this initiative, we aim to encourage early diagnosis and preventive care in oral health, an area that often gets neglected until symptoms become severe. At Aster, we are committed to putting powerful tools into the hands of our patients—literally—so they can take charge of their health with confidence and ease.' A recent survey conducted on UAE residents revealed that 80% of participants suffer from dental caries, with 50% visiting a dentist only when in pain, and just 20% making annual dental visits. These alarming statistics highlight the pressing need for regular dental screening and education about oral hygiene. Poor oral hygiene, sugary diets, and low awareness continue to be key contributors. Other prevalent oral health issues include gum and periodontal diseases, plaque and tartar deposits, stains, and mouth sores, as indicated by the survey.[1] Dr. Sherbaz Bichu, CEO of Aster Hospitals and Clinics – UAE, Oman, and Bahrain, commented 'Oral health is a window to overall well-being. Yet, many residents delay dental visits due to fear, cost, or inconvenience. With Smyl AI, we've created an experience that's quick, non-intrusive, and empowering. Our goal is to integrate technology and care—making dental assessments not only more accurate but also more approachable for families, working professionals, and communities across the UAE.' Smyl AI is accessible via WhatsApp by visiting and starting a chat with 'Hi Aster UAE.' From there, users can select their preferred language, input personal details, upload photos, and receive a comprehensive screening report—entirely free of cost. The tool instantly connects users with Aster Clinic's network of 30+ expert dental specialists for personalized treatment and trusted care. The tool ensures data privacy by complying with UAE healthcare information protection regulations and using secure, encrypted transmission protocols. All patient data is handled with utmost confidentiality and stored only with user consent. With a strong legacy of healthcare excellence, Aster's dental team offers professional advice, compassionate care, and reliable treatment outcomes you can trust. With a growing footprint of 110 Aster Clinics across the UAE, this first-of-its-kind initiative positions Aster Clinics as a pioneer in integrating AI into mainstream dental care. While currently in pilot phase at Aster Clinic Jumeirah Lakes Towers (JLT), the Smyl AI dental screening tool will soon be rolled out across Aster Clinics throughout the UAE. In line with the UAE's vision for improving healthcare access and awareness, Aster Clinics is committed to using innovative solutions like Smyl AI to drive positive changes in the oral health landscape.
